跳至主要内容
临床试验/NCT01283958
NCT01283958已完成不适用

Study of the Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome

Gachon University Gil Medical Center0 个研究点目标入组 12 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization

排除标准

  • 未提供

研究者

申办方类型
Other

相似试验

The Effects of Inhaled Iloprost on Congenital Heart... | 临床试验